Publication details

Burkittův lymfom: přehled patofyziologie, diagnostiky a terapie

Title in English Burkitt's lymphoma: pathophysiology, diagnostics and treatment
Authors

ŠMARDOVÁ Lenka VÁŠOVÁ Ingrid NAVRÁTIL Milan KŘENOVÁ Zdenka ŠÁLEK David MAREČKOVÁ Andrea KŘEN Leoš BOLČÁK Karol VORLÍČEK Jiří MAYER Jiří

Year of publication 2008
Type Article in Periodical
Magazine / Source Transfúze a hematologie dnes
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords Burkitts lymphoma; Epstein-Barr virus; molecular biology; c-myc; tumor lysis syndrom; chemotherapy
Description Burkitts lymphoma is a highly aggressive mature B-cell malignancy with a characteristic chromosomal translocation of c-myc proto-oncogene. Clinically, it manifests mostly by an extranodal involvement, affection the gastrointestinal system and usually by developing of a big tumor mass. Burkitts lymphoma requires an early medical treatment that is nowadays based on intensive combined cycles of chemotherapeutic agents. A part of the therapy includes a prophylaxis of the affection of central nervous system by tumor cells, where high-dose methotrexate, cytosinarabinosid and intrathecal therapy is used. With respect to regular CD20 positivity in cancer cells, the best curative outcome is achieved by a combination of cytostatic agents therapy with a monoclonal antibody therapy rituximab. Burkitts lymphoma is nowadays ranked among potentially curable diseases.

You are running an old browser version. We recommend updating your browser to its latest version.

More info